Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli Infections | 20 | 2025 | 59 | 6.500 |
Why?
|
| Diarrhea | 16 | 2025 | 72 | 4.580 |
Why?
|
| Enterotoxigenic Escherichia coli | 11 | 2023 | 26 | 3.210 |
Why?
|
| Escherichia coli | 15 | 2025 | 103 | 2.360 |
Why?
|
| Gastroenteritis | 4 | 2022 | 15 | 2.340 |
Why?
|
| Hemolytic-Uremic Syndrome | 3 | 2025 | 4 | 2.210 |
Why?
|
| Escherichia coli Proteins | 9 | 2020 | 43 | 2.170 |
Why?
|
| Enteropathogenic Escherichia coli | 7 | 2018 | 9 | 2.140 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 4 | 2025 | 7 | 1.990 |
Why?
|
| Hepatitis C | 2 | 2023 | 49 | 1.430 |
Why?
|
| Fimbriae, Bacterial | 6 | 2013 | 8 | 1.360 |
Why?
|
| Bacterial Toxins | 5 | 2016 | 27 | 1.170 |
Why?
|
| Bacterial Adhesion | 10 | 2016 | 16 | 1.160 |
Why?
|
| Infant | 14 | 2024 | 1024 | 1.100 |
Why?
|
| Child | 13 | 2025 | 2446 | 1.080 |
Why?
|
| Child, Preschool | 14 | 2024 | 1248 | 0.990 |
Why?
|
| Colombia | 9 | 2024 | 11 | 0.970 |
Why?
|
| Feces | 9 | 2024 | 50 | 0.920 |
Why?
|
| Cryptosporidium | 2 | 2022 | 2 | 0.900 |
Why?
|
| Cryptosporidiosis | 2 | 2022 | 4 | 0.900 |
Why?
|
| Salmonella | 5 | 2020 | 11 | 0.890 |
Why?
|
| Hepacivirus | 2 | 2023 | 42 | 0.890 |
Why?
|
| Anti-Bacterial Agents | 11 | 2025 | 336 | 0.880 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2023 | 40 | 0.870 |
Why?
|
| Secondary Prevention | 2 | 2025 | 75 | 0.870 |
Why?
|
| Epithelial Cells | 5 | 2015 | 137 | 0.840 |
Why?
|
| Enterobacteriaceae | 2 | 2018 | 14 | 0.840 |
Why?
|
| Food Microbiology | 3 | 2015 | 4 | 0.830 |
Why?
|
| Bacteriophages | 1 | 2024 | 3 | 0.830 |
Why?
|
| Phylogeny | 8 | 2022 | 75 | 0.830 |
Why?
|
| Shigella | 2 | 2022 | 10 | 0.790 |
Why?
|
| Polymerase Chain Reaction | 4 | 2020 | 189 | 0.760 |
Why?
|
| Carrier State | 3 | 2018 | 25 | 0.760 |
Why?
|
| Genotype | 4 | 2022 | 706 | 0.740 |
Why?
|
| Cryptosporidium parvum | 1 | 2022 | 3 | 0.740 |
Why?
|
| Escherichia coli O157 | 2 | 2020 | 2 | 0.720 |
Why?
|
| Infant, Newborn | 8 | 2023 | 674 | 0.720 |
Why?
|
| Genetic Variation | 5 | 2022 | 252 | 0.720 |
Why?
|
| Humans | 37 | 2025 | 32284 | 0.710 |
Why?
|
| Intestines | 3 | 2018 | 66 | 0.690 |
Why?
|
| Adhesins, Bacterial | 4 | 2023 | 6 | 0.680 |
Why?
|
| Bacterial Proteins | 6 | 2007 | 99 | 0.670 |
Why?
|
| Campylobacter | 3 | 2024 | 5 | 0.660 |
Why?
|
| beta-Lactamases | 3 | 2018 | 16 | 0.610 |
Why?
|
| Cephalosporin Resistance | 1 | 2018 | 1 | 0.560 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2018 | 3 | 0.560 |
Why?
|
| Animals | 17 | 2025 | 8165 | 0.560 |
Why?
|
| Antigens, Bacterial | 9 | 2023 | 24 | 0.560 |
Why?
|
| DNA, Bacterial | 7 | 2018 | 35 | 0.530 |
Why?
|
| HIV Infections | 1 | 2023 | 451 | 0.530 |
Why?
|
| Case-Control Studies | 5 | 2024 | 858 | 0.520 |
Why?
|
| Salmonella Infections | 2 | 2020 | 12 | 0.510 |
Why?
|
| Escherichia coli Vaccines | 1 | 2016 | 12 | 0.470 |
Why?
|
| Plasmodium falciparum | 3 | 2007 | 8 | 0.470 |
Why?
|
| Prevalence | 5 | 2018 | 960 | 0.460 |
Why?
|
| Bordetella pertussis | 1 | 2015 | 8 | 0.460 |
Why?
|
| Respiratory Mucosa | 1 | 2015 | 13 | 0.460 |
Why?
|
| Whooping Cough | 1 | 2015 | 11 | 0.460 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 41 | 0.460 |
Why?
|
| Genes, Bacterial | 4 | 2016 | 13 | 0.450 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 27 | 0.450 |
Why?
|
| Food Contamination | 1 | 2015 | 3 | 0.440 |
Why?
|
| Malaria Vaccines | 2 | 2007 | 3 | 0.430 |
Why?
|
| Protozoan Proteins | 2 | 2007 | 11 | 0.420 |
Why?
|
| Salmonella typhi | 3 | 2007 | 14 | 0.410 |
Why?
|
| Fimbriae Proteins | 4 | 2015 | 9 | 0.410 |
Why?
|
| Tennessee | 3 | 2020 | 101 | 0.410 |
Why?
|
| Colostrum | 2 | 2025 | 2 | 0.400 |
Why?
|
| Mice | 10 | 2023 | 2544 | 0.400 |
Why?
|
| Models, Biological | 1 | 2015 | 403 | 0.390 |
Why?
|
| Immunity, Mucosal | 4 | 2022 | 10 | 0.380 |
Why?
|
| Molecular Sequence Data | 9 | 2010 | 368 | 0.380 |
Why?
|
| Campylobacter Infections | 2 | 2024 | 7 | 0.370 |
Why?
|
| Female | 14 | 2024 | 19954 | 0.370 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2025 | 548 | 0.360 |
Why?
|
| Virulence Factors | 3 | 2016 | 14 | 0.340 |
Why?
|
| Colitis, Ulcerative | 2 | 2023 | 26 | 0.330 |
Why?
|
| Crohn Disease | 2 | 2023 | 33 | 0.330 |
Why?
|
| Pregnancy | 3 | 2023 | 963 | 0.320 |
Why?
|
| Vibrio cholerae | 2 | 2008 | 5 | 0.320 |
Why?
|
| Carrier Proteins | 3 | 2014 | 148 | 0.320 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2023 | 27 | 0.310 |
Why?
|
| Bacterial Vaccines | 3 | 1999 | 11 | 0.310 |
Why?
|
| Cattle | 3 | 2021 | 118 | 0.310 |
Why?
|
| Bacterial Outer Membrane Proteins | 4 | 1999 | 10 | 0.310 |
Why?
|
| Vaccines, DNA | 2 | 2007 | 6 | 0.300 |
Why?
|
| Serotyping | 4 | 2018 | 21 | 0.300 |
Why?
|
| Helicobacter pylori | 2 | 1999 | 10 | 0.280 |
Why?
|
| Helicobacter Infections | 2 | 1999 | 11 | 0.280 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 1997 | 13 | 0.270 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2007 | 4 | 0.270 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2007 | 5 | 0.270 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2007 | 4 | 0.270 |
Why?
|
| Multigene Family | 1 | 2007 | 51 | 0.260 |
Why?
|
| Salmonella typhimurium | 2 | 1998 | 36 | 0.260 |
Why?
|
| Immunization, Secondary | 1 | 2007 | 13 | 0.260 |
Why?
|
| Peptide Hydrolases | 2 | 2019 | 19 | 0.260 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2025 | 13 | 0.230 |
Why?
|
| Amino Acid Sequence | 5 | 2010 | 293 | 0.230 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2016 | 23 | 0.230 |
Why?
|
| Antibodies, Monoclonal | 2 | 2025 | 246 | 0.220 |
Why?
|
| Pentosan Sulfuric Polyester | 1 | 2025 | 5 | 0.220 |
Why?
|
| Polystyrenes | 1 | 2025 | 4 | 0.220 |
Why?
|
| Cell Membrane | 1 | 2025 | 109 | 0.220 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2023 | 30 | 0.220 |
Why?
|
| Male | 8 | 2024 | 19434 | 0.220 |
Why?
|
| Bacterial Typing Techniques | 2 | 2018 | 16 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 135 | 0.210 |
Why?
|
| Sewage | 1 | 2024 | 1 | 0.210 |
Why?
|
| Plasmids | 4 | 2016 | 53 | 0.200 |
Why?
|
| Bacteria | 1 | 2024 | 55 | 0.200 |
Why?
|
| Risk Factors | 3 | 2022 | 3938 | 0.200 |
Why?
|
| New York | 1 | 2023 | 21 | 0.200 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2025 | 81 | 0.200 |
Why?
|
| RNA, Viral | 1 | 2023 | 51 | 0.200 |
Why?
|
| Adult | 4 | 2025 | 9263 | 0.190 |
Why?
|
| Immunization | 3 | 2016 | 41 | 0.190 |
Why?
|
| Tetanus Toxin | 3 | 2000 | 8 | 0.190 |
Why?
|
| Vegetables | 2 | 2015 | 41 | 0.190 |
Why?
|
| DNA, Protozoan | 1 | 2022 | 5 | 0.180 |
Why?
|
| Genetic Vectors | 2 | 2007 | 109 | 0.180 |
Why?
|
| Biofilms | 1 | 2022 | 23 | 0.180 |
Why?
|
| Vitronectin | 3 | 1998 | 5 | 0.170 |
Why?
|
| Neisseria gonorrhoeae | 3 | 1998 | 11 | 0.170 |
Why?
|
| United States | 2 | 2022 | 4079 | 0.170 |
Why?
|
| Organosilicon Compounds | 1 | 2021 | 1 | 0.170 |
Why?
|
| Trisaccharides | 1 | 2021 | 2 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2018 | 2320 | 0.170 |
Why?
|
| Placebos | 1 | 2021 | 69 | 0.170 |
Why?
|
| Mothers | 1 | 2022 | 75 | 0.170 |
Why?
|
| Antigens, Protozoan | 1 | 2001 | 1 | 0.170 |
Why?
|
| Cells, Cultured | 3 | 2013 | 821 | 0.160 |
Why?
|
| Shiga Toxin | 1 | 2020 | 3 | 0.160 |
Why?
|
| Astroviridae Infections | 1 | 2020 | 1 | 0.160 |
Why?
|
| Caliciviridae Infections | 1 | 2020 | 2 | 0.160 |
Why?
|
| Norovirus | 1 | 2020 | 3 | 0.160 |
Why?
|
| Adolescent | 2 | 2018 | 3521 | 0.160 |
Why?
|
| Rotavirus | 1 | 2020 | 4 | 0.160 |
Why?
|
| Rotavirus Infections | 1 | 2020 | 9 | 0.160 |
Why?
|
| Adenoviridae Infections | 1 | 2020 | 15 | 0.160 |
Why?
|
| Adenoviridae | 1 | 2020 | 66 | 0.160 |
Why?
|
| Peptide Fragments | 3 | 2000 | 417 | 0.150 |
Why?
|
| Developing Countries | 2 | 2011 | 59 | 0.150 |
Why?
|
| Enterotoxins | 2 | 1999 | 11 | 0.150 |
Why?
|
| Genomics | 1 | 2020 | 89 | 0.150 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 112 | 0.150 |
Why?
|
| Diphtheria Toxin | 2 | 1997 | 30 | 0.150 |
Why?
|
| Rhinitis, Atrophic | 1 | 2019 | 1 | 0.150 |
Why?
|
| Klebsiella Infections | 1 | 2019 | 7 | 0.140 |
Why?
|
| Immunotherapy, Active | 1 | 1998 | 7 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 4 | 2007 | 199 | 0.140 |
Why?
|
| Incidence | 1 | 2021 | 1244 | 0.130 |
Why?
|
| Vaccines, Attenuated | 4 | 1999 | 16 | 0.130 |
Why?
|
| Acute Disease | 1 | 2018 | 253 | 0.130 |
Why?
|
| Virulence | 2 | 2016 | 22 | 0.130 |
Why?
|
| Tetanus Toxoid | 1 | 1997 | 2 | 0.130 |
Why?
|
| Vaccines, Synthetic | 1 | 1997 | 15 | 0.130 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2007 | 77 | 0.130 |
Why?
|
| Base Sequence | 5 | 2000 | 256 | 0.120 |
Why?
|
| Drug Resistance, Multiple | 1 | 2016 | 8 | 0.120 |
Why?
|
| Drug Resistance, Microbial | 1 | 2016 | 14 | 0.120 |
Why?
|
| Histoplasmosis | 1 | 2016 | 3 | 0.120 |
Why?
|
| Meningoencephalitis | 1 | 2016 | 5 | 0.120 |
Why?
|
| Survival Analysis | 2 | 2016 | 478 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2007 | 122 | 0.120 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2015 | 9 | 0.120 |
Why?
|
| Bronchi | 1 | 2015 | 34 | 0.110 |
Why?
|
| Hospitalization | 1 | 2018 | 476 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 25 | 0.110 |
Why?
|
| Cheese | 1 | 2015 | 2 | 0.110 |
Why?
|
| Retrospective Studies | 1 | 2023 | 3612 | 0.110 |
Why?
|
| Food Handling | 1 | 2015 | 8 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2015 | 121 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 213 | 0.110 |
Why?
|
| Receptors, Cell Surface | 2 | 2014 | 78 | 0.110 |
Why?
|
| Cloning, Molecular | 3 | 2008 | 77 | 0.110 |
Why?
|
| Phenotype | 1 | 2016 | 619 | 0.110 |
Why?
|
| Ampicillin Resistance | 1 | 2014 | 1 | 0.100 |
Why?
|
| Trimethoprim Resistance | 1 | 2014 | 1 | 0.100 |
Why?
|
| Vaccination | 1 | 2016 | 156 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2022 | 3410 | 0.100 |
Why?
|
| Transcription Factors | 1 | 1995 | 184 | 0.100 |
Why?
|
| Mice, Inbred DBA | 1 | 2013 | 43 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2013 | 66 | 0.100 |
Why?
|
| Animals, Newborn | 1 | 2013 | 137 | 0.090 |
Why?
|
| Swine | 1 | 2013 | 229 | 0.090 |
Why?
|
| Salmonella Vaccines | 1 | 2011 | 2 | 0.090 |
Why?
|
| Developed Countries | 1 | 2011 | 7 | 0.090 |
Why?
|
| Typhoid Fever | 1 | 2011 | 21 | 0.090 |
Why?
|
| Disease Outbreaks | 1 | 2011 | 41 | 0.090 |
Why?
|
| Remission Induction | 2 | 2023 | 94 | 0.080 |
Why?
|
| DNA Primers | 2 | 2008 | 85 | 0.080 |
Why?
|
| Microbial Viability | 1 | 2010 | 6 | 0.080 |
Why?
|
| Muramidase | 1 | 2010 | 9 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 38 | 0.080 |
Why?
|
| Meat | 1 | 2010 | 17 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 64 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 60 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 113 | 0.080 |
Why?
|
| Immunoblotting | 2 | 2019 | 54 | 0.080 |
Why?
|
| Mutation | 2 | 2010 | 497 | 0.070 |
Why?
|
| Yersinia enterocolitica | 1 | 2008 | 1 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 555 | 0.070 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2008 | 15 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 1073 | 0.070 |
Why?
|
| Antibodies, Bacterial | 2 | 1998 | 36 | 0.070 |
Why?
|
| Mycoplasma Infections | 1 | 2007 | 2 | 0.070 |
Why?
|
| Antibodies, Protozoan | 1 | 2007 | 1 | 0.060 |
Why?
|
| Hemolysin Proteins | 1 | 2007 | 2 | 0.060 |
Why?
|
| Epitopes | 1 | 2007 | 27 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2007 | 60 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2007 | 54 | 0.060 |
Why?
|
| Age Factors | 1 | 2010 | 1179 | 0.060 |
Why?
|
| Pakistan | 2 | 2016 | 4 | 0.060 |
Why?
|
| Models, Animal | 1 | 2007 | 189 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 755 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 502 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2025 | 88 | 0.060 |
Why?
|
| Micronutrients | 1 | 2024 | 21 | 0.050 |
Why?
|
| Metabolomics | 1 | 2024 | 63 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 1995 | 499 | 0.050 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2016 | 42 | 0.050 |
Why?
|
| Hela Cells | 3 | 1998 | 75 | 0.050 |
Why?
|
| Liposomes | 1 | 2023 | 35 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 1052 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2001 | 55 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2001 | 38 | 0.040 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2000 | 1 | 0.040 |
Why?
|
| Epithelium | 2 | 1997 | 24 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 94 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 151 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 1999 | 44 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 43 | 0.040 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1998 | 4 | 0.040 |
Why?
|
| Head | 1 | 2019 | 57 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2001 | 776 | 0.030 |
Why?
|
| Receptors, Fibronectin | 1 | 1998 | 1 | 0.030 |
Why?
|
| Urease | 1 | 1998 | 2 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 1999 | 105 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 1998 | 15 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 1998 | 26 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 287 | 0.030 |
Why?
|
| Blood | 1 | 1997 | 14 | 0.030 |
Why?
|
| Laminin | 1 | 1997 | 14 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1997 | 7 | 0.030 |
Why?
|
| Fibronectins | 1 | 1997 | 40 | 0.030 |
Why?
|
| Fibrinogen | 1 | 1997 | 66 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 971 | 0.030 |
Why?
|
| Administration, Oral | 1 | 1998 | 201 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 1997 | 73 | 0.030 |
Why?
|
| Tetanus Antitoxin | 1 | 1997 | 1 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 1997 | 36 | 0.030 |
Why?
|
| Lepidoptera | 1 | 2016 | 1 | 0.030 |
Why?
|
| DNA Topoisomerase IV | 1 | 2016 | 1 | 0.030 |
Why?
|
| DNA Gyrase | 1 | 2016 | 2 | 0.030 |
Why?
|
| Moths | 1 | 2016 | 3 | 0.030 |
Why?
|
| Biological Assay | 1 | 2016 | 19 | 0.030 |
Why?
|
| Intestine, Small | 1 | 1996 | 44 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 86 | 0.030 |
Why?
|
| Chromosomes, Bacterial | 1 | 1995 | 4 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 1995 | 41 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 70 | 0.030 |
Why?
|
| Gene Frequency | 1 | 1995 | 212 | 0.030 |
Why?
|
| Pediatrics | 1 | 2016 | 157 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 906 | 0.030 |
Why?
|
| Time Factors | 1 | 1997 | 2196 | 0.020 |
Why?
|
| Costa Rica | 1 | 2010 | 2 | 0.020 |
Why?
|
| Protein Kinase C | 2 | 1998 | 45 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 165 | 0.020 |
Why?
|
| Endocytosis | 1 | 1998 | 10 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1998 | 19 | 0.010 |
Why?
|
| Biopolymers | 1 | 1998 | 8 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1998 | 18 | 0.010 |
Why?
|
| Actins | 1 | 1998 | 51 | 0.010 |
Why?
|
| Microspheres | 1 | 1998 | 46 | 0.010 |
Why?
|
| Ligands | 1 | 1998 | 90 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 172 | 0.010 |
Why?
|
| Peptides | 1 | 1998 | 128 | 0.010 |
Why?
|
| Reducing Agents | 1 | 1996 | 1 | 0.010 |
Why?
|
| Mercaptoethanol | 1 | 1996 | 2 | 0.010 |
Why?
|
| Flagella | 1 | 1996 | 4 | 0.010 |
Why?
|
| Cecum | 1 | 1996 | 11 | 0.010 |
Why?
|
| Movement | 1 | 1996 | 62 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1996 | 75 | 0.010 |
Why?
|